Sanofi-Aventis

Contact
en.sanofi.com
+33153774000

sanofi-aventis Groupe

54, rue La Boétie
75008 Paris
France
+33153774000
en.sanofi.com
Contact
Profile Products News
Contact

About Sanofi-Aventis

We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people's lives.

Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.

Read more about Sanofi-Aventis
Facts about Sanofi-Aventis
  • Focus : Manufacturer
  • Industry : Pharma

Product portfolio of Sanofi-Aventis

Product portfolio

Show all

News about Sanofi-Aventis

Sanofi-Aventis

20-May-2024 | business & finance

Sartorius collaborates with Sanofi to

Commercialization of end-to-end platform for downstream process intensification

Read news
Sanofi-Aventis

20-Jun-2023 | people

First woman to head research & development at Sanofi in Germany

Marion Zerlin succeeds Jochen Maas, who is retiring

Read news
Sanofi-Aventis

02-May-2023 | business & finance

Sanofi completes acquisition of Provention Bio

Sanofi and Provention Bio, Inc., a U.S.-based, publicly traded biopharmaceutical company focused on intercepting and preventing immune-mediated diseases ...

Read news
Sanofi-Aventis

29-Nov-2022 | business & finance

Sanofi moves into its new Paris global headquarters

The opening is part of a global program to modernize the Group's workspaces around the world

Read news
Sanofi-Aventis

22-Dec-2021 | business & finance

Sanofi to acquire Amunix immuno-oncology pipeline with next generation Conditionally Activated Biologics

Sanofi announced that it has entered into an agreement to acquire Amunix Pharmaceuticals, Inc., an immuno-oncology company leveraging its proprietary, ...

Read news
Sanofi-Aventis

09-Sep-2021 | business & finance

Sanofi to acquire Kadmon

Sanofi has entered into a definitive merger agreement with Kadmon Holdings, Inc. a biopharmaceutical company that discovers, develops, and markets ...

Read news
Sanofi-Aventis

05-Aug-2021 | business & finance

Sanofi to acquire Translate Bio

Accelerates development of current Sanofi licensed programs in vaccines and potential to explore other therapeutic areas

Read news
Sanofi-Aventis

02-Nov-2020 | business & finance

Sanofi offers to acquire Kiadis

Adds proprietary next generation natural killer (K-NK) cell platform and pipeline of cell-based cancer immune-therapeutics and infectious disease therapies

Read news
Show more news about Sanofi-Aventis

Here you will find sanofi-aventis Groupe